Salvi A - Search Results

1

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.

Salvi A, Abeni E, Portolani N, Barlati S, De Petro G. Salvi A, et al. Int J Oncol. 2013 Feb;42(2):391-402. doi: 10.3892/ijo.2012.1716. Epub 2012 Nov 28. Int J Oncol. 2013. PMID: 23229173 Free PMC article.

2

Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.

Tavian D, Salvi A, De Petro G, Barlati S. Tavian D, et al. Among authors: salvi a. Cancer Gene Ther. 2003 Feb;10(2):112-20. doi: 10.1038/sj.cgt.7700533. Cancer Gene Ther. 2003. PMID: 12536199

3

Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.

Nodari F, Baiocchi GL, Salvi A, De Petro G, Coniglio A, Ferrari Bravo A, Baronchelli C, Barlati S, Giulini SM. Nodari F, et al. Among authors: salvi a. Acta Biomed. 2003;74 Suppl 2:59-64. Acta Biomed. 2003. PMID: 15055037

4

Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells.

Salvi A, Arici B, De Petro G, Barlati S. Salvi A, et al. Mol Cancer Ther. 2004 Jun;3(6):671-8. Mol Cancer Ther. 2004. PMID: 15210852

5

RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice.

Salvi A, Arici B, Alghisi A, Barlati S, De Petro G. Salvi A, et al. Tumour Biol. 2007;28(1):16-26. doi: 10.1159/000097699. Epub 2006 Dec 5. Tumour Biol. 2007. PMID: 17159381

6

The FN13 peptide inhibits human tumor cells invasion through the modulation of alpha v beta 3 integrins organization and the inactivation of ILK pathway.

Zoppi N, Ritelli M, Salvi A, Colombi M, Barlati S. Zoppi N, et al. Among authors: salvi a. Biochim Biophys Acta. 2007 Jun;1773(6):747-63. doi: 10.1016/j.bbamcr.2007.02.007. Epub 2007 Feb 24. Biochim Biophys Acta. 2007. PMID: 17383746 Free article.

7

In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.

Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S. Salvi A, et al. Int J Oncol. 2007 Aug;31(2):451-60. Int J Oncol. 2007. PMID: 17611703

8

Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.

Salvi A, Marchina E, Benetti A, Grigolato P, De Petro G, Barlati S. Salvi A, et al. Int J Oncol. 2008 Aug;33(2):271-6. Int J Oncol. 2008. PMID: 18636147

9

RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

Cassinelli G, Favini E, Degl'Innocenti D, Salvi A, De Petro G, Pierotti MA, Zunino F, Borrello MG, Lanzi C. Cassinelli G, et al. Among authors: salvi a. Neoplasia. 2009 Jan;11(1):10-21. doi: 10.1593/neo.08916. Neoplasia. 2009. PMID: 19107227 Free PMC article.

10

Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.

Salvi A, Bongarzone I, Miccichè F, Arici B, Barlati S, De Petro G. Salvi A, et al. Neoplasia. 2009 Feb;11(2):207-19. doi: 10.1593/neo.81076. Neoplasia. 2009. PMID: 19177205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters